Noida Chronicle

Invasive Aspergillosis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Pulmocide, F2G Biotech GmbH, Scynexis, Biosergen, CSPC Ouyi

Invasive Aspergillosis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Pulmocide, F2G Biotech GmbH, Scynexis, Biosergen, CSPC Ouyi

The Invasive Aspergillosis Market Forecast report offers an in-depth understanding of the Invasive Aspergillosis, historical and forecasted epidemiology as well as the Invasive Aspergillosis market trends in the 7MM. DelveInsight’s

Read Full Article

Primary Sclerosing Cholangitis Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Engitix, GRI Bio, Qing Bile Therapeutics, Sirnaomics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Primary Sclerosing Cholangitis pipeline constitutes 14+ key companies continuously working towards developing 14+ Primary Sclerosing Cholangitis treatment therapies, analysis of

Read Full Article

Cutaneous T-Cell Lymphoma (CTCL) Market Size was USD 520 million in 2023, estimates DelveInsight | 4SC, Bio-Path Holdings, BioInvent International, Bioniz Therapeutics, Citius Pharmaceuticals, Roche

Cutaneous T-Cell Lymphoma Market Cutaneous T-Cell Lymphoma (CTCL) Companies are 4SC, Bio-Path Holdings, BioInvent International AB, Bioniz Therapeutics, Citius Pharmaceuticals, Codiak BioSciences, Elorac, Equillium, Genzada Pharmaceuticals, Hoffmann-La Roche, Innate Pharma,

Read Full Article

Pompe Disease Market to witness growth by 2032, estimates DelveInsight | Spark Therapeutics, Amicus Therapeutics, Asklepios Biopharmaceutical, Audentes Therapeutics, Rocket Pharmaceuticals, Avidity

Pompe Disease Market Pompe Disease companies are Spark Therapeutics, Amicus Therapeutics, Asklepios Biopharmaceutical, Audentes Therapeutics, Rocket Pharmaceuticals, Avidity Biosciences, AVROBIO, Maze Therapeutics, Denali Therapeutics, Novartis, Fresenius Kabi AG, Akorn Incorporated,

Read Full Article

Multiple Myeloma Market size was USD 21,300 million in 2023, estimates DelveInsight | GlaxoSmithKline, Bristol-Myers Squibb, Bluebird bio, Oncopeptides AB, Secura Bio, Amgen, Takeda, Pfizer, more

Multiple Myeloma Market Multiple Myeloma companies are GlaxoSmithKline, Bristol-Myers Squibb, Bluebird bio, Oncopeptides AB, Secura Bio, Amgen, Takeda, Millennium Pharmaceuticals,

Read Full Article

Crohn’s Disease Pipeline Assessment 2024: Clinical Trials, FDA, EMA, PDMA Approvals, Therapies, Treatment Market, Mechanism of Action, Route of Administration by DelveInsight

Crohn’s Disease Pipeline As per DelveInsight’s assessment, globally, Crohn’s Disease pipeline constitutes 70+ key companies continuously working towards developing 75+

Read Full Article

Pre-filled Syringes Market is expected to grow at a CAGR of 10.44%, estimates DelveInsight

Pre-filled Syringes Market Prefilled Syringes companies are BD, NIPRO Pharma, Taisei Kako Co.,Ltd, TERUMO PHARMACEUTICAL SOLUTIONS., SCHOTT AG, Gerresheimer AG,

Read Full Article

Image-Guided Surgery Devices Market is expected to grow exponentially at a CAGR of 5.81% by 2030, estimates DelveInsight

Image-Guided Surgery Devices Market Image-Guided Surgery Devices companies include Koninklijke Philips N.V., Medtronic, Siemens Healthineers, General Electric Company, Varian Medical

Read Full Article

Non-hodgkin’s Lymphoma Market to Showcase Significant Growth During the Forecast Period | Zentera, Pacylex, Novartis, Loxo Oncology, Abbvie, Angiocrine

Non-Hodgkin’s Lymphoma Market Non-Hodgkin lymphoma epidemiology is segmented as Total Incident Cases of NHL, Type-specific Incident Cases of NHL, Stage-specific

Read Full Article

Chronic Lymphocytic Leukemia Clinical Updates 2024 | FDA Approvals, Therapies in Focus, Octapharma, Celgene, Loxo Oncology, Janssen Research & Development, LLC, TG therapeutics, AFA Insurance

Chronic Lymphocytic Leukemia Pipeline Insight DelveInsight’s, “Chronic Lymphocytic Leukemia (CLL) – Pipeline Insight, 2024,” report provides comprehensive insights about 55+

Read Full Article